Literature DB >> 25034468

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.

Jee-Hyun Yoon1, Ji-Sun Nam, Kyung-Jin Kim, Young-Tae Ro.   

Abstract

To investigate the effect of natural pyrazinamidase (PncA) mutations on protein function, we analyzed expression and PncA activity of eight pncA point mutants identified in nineteen pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates. Among them, two mutants (Y99D and T135P) showed high expression level and solubility comparable to those of the wild-type PncA protein, two (K48E and G97D) displayed low expression level and solubility, and four (C14R, H51P, W68S, and A146V) were insoluble. Interestingly, when possible structural effects of these mutations were predicted by the CUPSAT program based on the proposed three-dimensional structure of M. tuberculosis PncA, only two highly soluble mutant proteins (Y99D and T135P) were predicted to be stabilizing and have favorable torsion angles. However, the others exhibiting either low solubility or precipitation were foreseen to be destabilizing and/or have unfavorable torsion angles, suggesting that the alterations could interfere with proper protein folding, thereby decreasing or depleting protein solubility. A PncA activity assay demonstrated that two mutants (G97D and T135P) showed virtually no activity, but two other mutants (K48E and Y99D) exhibited wild-type activity, indicating that the PncA residues (Cys14, His51, Trp68, Gly97, Thr135, and Ala146) may be important for PncA activity and/or proper protein folding.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034468     DOI: 10.1007/s11274-014-1706-0

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  35 in total

1.  Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea.

Authors:  Jee-Hyun Yoon; Ji-Sun Nam; Kyung-Jin Kim; Yeonim Choi; Hyeyoung Lee; Sang-Nae Cho; Young-Tae Ro
Journal:  Diagn Microbiol Infect Dis       Date:  2011-11-10       Impact factor: 2.803

2.  Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii.

Authors:  X Du; W Wang; R Kim; H Yakota; H Nguyen; S H Kim
Journal:  Biochemistry       Date:  2001-11-27       Impact factor: 3.162

3.  pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.

Authors:  S J Cheng; L Thibert; T Sanchez; L Heifets; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.

Authors:  D E Snider; J Graczyk; E Bek; J Rogowski
Journal:  Am Rev Respir Dis       Date:  1984-12

5.  Rapid isolation of high molecular weight plant DNA.

Authors:  M G Murray; W F Thompson
Journal:  Nucleic Acids Res       Date:  1980-10-10       Impact factor: 16.971

6.  Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.

Authors:  Karolien Stoffels; Vanessa Mathys; Maryse Fauville-Dufaux; René Wintjens; Pablo Bifani
Journal:  Antimicrob Agents Chemother       Date:  2012-07-23       Impact factor: 5.191

7.  Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Authors:  G P Morlock; J T Crawford; W R Butler; S E Brim; D Sikes; G H Mazurek; C L Woodley; R C Cooksey
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.

Authors:  N Lemaitre; I Callebaut; F Frenois; V Jarlier; W Sougakoff
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

9.  Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.

Authors:  K W Lee; J M Lee; K S Jung
Journal:  J Korean Med Sci       Date:  2001-10       Impact factor: 2.153

10.  CUPSAT: prediction of protein stability upon point mutations.

Authors:  Vijaya Parthiban; M Michael Gromiha; Dietmar Schomburg
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  11 in total

Review 1.  The Bewildering Antitubercular Action of Pyrazinamide.

Authors:  Elise A Lamont; Nicholas A Dillon; Anthony D Baughn
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

2.  Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.

Authors:  Farahnoosh Doustdar; Mohammad Pazhang; Faramarz Mehrnejad; Mehrnoosh Safarzadeh; Davod Rabiei; Nader Chaparzadeh; Hanieh Falahati; Mohammad Mir-Derikvand
Journal:  Protein J       Date:  2015-06       Impact factor: 2.371

3.  High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.

Authors:  Jean-Philippe Lanoix; Rokeya Tasneen; Paul O'Brien; Jansy Sarathy; Hassan Safi; Michael Pinn; David Alland; Véronique Dartois; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

4.  Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of Mycobacterium tuberculosis associated with pyrazinamide resistance.

Authors:  Muhammad Tahir Khan; Ashfaq Ur Rehaman; Muhammad Junaid; Shaukat Iqbal Malik; Dong-Qing Wei
Journal:  Comput Struct Biotechnol J       Date:  2018-10-04       Impact factor: 7.271

5.  Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.

Authors:  Muhammad Tahir Khan; Abbas Khan; Ashfaq Ur Rehman; Yanjie Wang; Khalid Akhtar; Shaukat Iqbal Malik; Dong-Qing Wei
Journal:  Sci Rep       Date:  2019-05-16       Impact factor: 4.379

6.  Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance.

Authors:  Aamir Mehmood; Muhammad Tahir Khan; Aman Chandra Kaushik; Anwar Sheed Khan; Muhammad Irfan; Dong-Qing Wei
Journal:  Front Bioeng Biotechnol       Date:  2019-12-10

7.  Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance.

Authors:  Muhammad Tahir Khan; Sajid Ali; Muhammad Tariq Zeb; Aman Chandra Kaushik; Shaukat Iqbal Malik; Dong-Qing Wei
Journal:  Front Mol Biosci       Date:  2020-04-09

8.  A computational perspective on the dynamic behaviour of recurrent drug resistance mutations in the pncA gene from Mycobacterium tuberculosis.

Authors:  Taimoor Khan; Abbas Khan; Syed Shujait Ali; Shahid Ali; Dong-Qing Wei
Journal:  RSC Adv       Date:  2021-01-11       Impact factor: 3.361

9.  Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.

Authors:  Rydberg Roman Supo-Escalante; Aldhair Médico; Eduardo Gushiken; Gustavo E Olivos-Ramírez; Yaneth Quispe; Fiorella Torres; Melissa Zamudio; Ricardo Antiparra; L Mario Amzel; Robert H Gilman; Patricia Sheen; Mirko Zimic
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

Review 10.  Impact of the host environment on the antitubercular action of pyrazinamide.

Authors:  Elise A Lamont; Anthony D Baughn
Journal:  EBioMedicine       Date:  2019-10-25       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.